Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ALLK

Allakos (ALLK)

Allakos Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALLK
DateTimeSourceHeadlineSymbolCompany
01/13/20253:07PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ALLKAllakos Inc
12/19/20243:15PMPR Newswire (US)Kuehn Law Encourages Investors of Allakos Inc. to Contact Law FirmNASDAQ:ALLKAllakos Inc
12/09/20245:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
12/06/20243:25PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALLKAllakos Inc
12/06/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
12/06/20243:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
12/05/20242:57PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALLKAllakos Inc
12/04/20243:23PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALLKAllakos Inc
11/18/20243:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALLKAllakos Inc
11/06/20243:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALLKAllakos Inc
11/06/20243:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALLKAllakos Inc
10/10/20243:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALLKAllakos Inc
10/10/20243:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALLKAllakos Inc
10/10/20243:02PMGlobeNewswire Inc.Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy VolunteersNASDAQ:ALLKAllakos Inc
09/12/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
09/11/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
09/11/20242:51PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALLKAllakos Inc
09/10/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
09/09/20243:29PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALLKAllakos Inc
09/06/20242:46PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALLKAllakos Inc
08/16/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALLKAllakos Inc
08/07/20243:08PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALLKAllakos Inc
08/07/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALLKAllakos Inc
08/07/20243:02PMGlobeNewswire Inc.Allakos Provides Business Update and Reports Second Quarter 2024 Financial ResultsNASDAQ:ALLKAllakos Inc
06/25/20243:02PMGlobeNewswire Inc.Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety ProfileNASDAQ:ALLKAllakos Inc
06/10/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
06/10/20244:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
06/07/20242:43PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALLKAllakos Inc
06/06/20243:14PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ALLKAllakos Inc
05/29/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ALLKAllakos Inc
 Showing the most relevant articles for your search:NASDAQ:ALLK